Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie seeks US approval of risankizumab for plaque psoriasis; reports positive data for upadacitinib in rheumatoid arthritis

firstwordpharmaApril 26, 2018

Tag: AbbVie , risansizumab

PharmaSources Customer Service